IP Library Granted Patent US 8,450,273
Granted Patent B2
US 8,450,273 · App. 12/594,547 · Granted May 28, 2013

Fusion proteins of collagen-binding domain and parathyroid hormone

Inventors: Joshua Sakon (Fayetteville, AR); Robert C. Gensure (Luling, LA); Osamu Matsushita (Kanagawa, JP)
Assignees: The Board of Trustees of the University of Arkansas; Ochsner Clinic Foundation; National University Corporation Kagawa University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,450,273
App. No.
12/594,547
Granted
May 28, 2013
Kind
B2
Abstract

Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.

Claims (8)

1. A composition comprising:

a collagen-binding polypeptide segment covalently linked to a PTH/PTHrP receptor agonist; wherein the collagen-binding polypeptide segment is a bacterial collagen binding polypeptide segment, wherein the PTH/PTHrP receptor agonist comprises residues 1-14 of SEQ ID NO: 1, and wherein the collagen-binding polypeptide segment comprises residues 38-158 of SEQ ID NO: 1, or is at least 90% identical to residues 38-158 of SEQ ID NO: 1.

2. The composition of claim 1 , wherein the collagen-binding polypeptide segment and the PTH/PTHrP receptor agonist are chemically cross-linked to each other or are polypeptide portions of a fusion protein.

3. The composition of claim 1 , wherein the N-terminus of the collagen-binding polypeptide segment is linked directly or through a linker polypeptide segment to the C-terminus of the PTH/PTHrP receptor agonist polypeptide.

4. The composition of claim 1 , wherein the composition comprises SEQ ID NO: 1.

5. The composition of claim 1 , wherein the composition comprises SEQ ID NO: 2.

6. The composition of claim 1 , wherein the PTH/PTHrP receptor agonist comprises residues 1-33 of SEQ ID NO: 1.

7. The composition of claim 1 , wherein the composition further comprises residues 37-251 of SEQ ID NO: 2 covalently linked to collagen binding polypeptide segment.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2009
From: GENSURE, ROBERT C.
To: OCHSNER CLINIC FOUNDATION
Reel/Frame 023322/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2009
From: MATSUSHITA, OSAMU
To: NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
Reel/Frame 023322/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2009
From: SAKON, JOSHUA
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 023322/0228 →
Continuity (2)
Provisional Application 60922433 · Apr 9, 2007
Related Publication 20100129341A1 · May 27, 2010